Your browser doesn't support javascript.
loading
Induction of eEF2-specific antitumor CTL responses in vivo by vaccination with eEF2-derived 9mer-peptides.
Nakajima, Hiroko; Murakami, Yui; Morii, Eiichi; Akao, Toshiki; Tatsumi, Naoya; Odajima, Satoko; Fukuda, Mari; Machitani, Takao; Iwai, Miki; Kawata, Sayo; Hojo, Nozomi; Oka, Yoshihiro; Sugiyama, Haruo; Oji, Yusuke.
Afiliação
  • Nakajima H; Department of Cancer Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Murakami Y; Department of Functional Diagnostic Sciences, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Morii E; Department of Pathology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Akao T; Department of Functional Diagnostic Sciences, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Tatsumi N; Department of Cancer Immunotherapy, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Odajima S; Department of Functional Diagnostic Sciences, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Fukuda M; Department of Functional Diagnostic Sciences, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Machitani T; Department of Functional Diagnostic Sciences, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Iwai M; Department of Functional Diagnostic Sciences, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Kawata S; Department of Functional Diagnostic Sciences, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Hojo N; Department of Functional Diagnostic Sciences, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Oka Y; Department of Cancer Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Sugiyama H; Department of Cancer Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Oji Y; Department of Cancer Stem Cell Biology, Osaka University Graduate School of Medicine, Osaka, Japan.
Oncol Rep ; 35(4): 1959-66, 2016 Apr.
Article em En | MEDLINE | ID: mdl-26820500

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fragmentos de Peptídeos / Linfócitos T Citotóxicos / Leucemia / Vacinas Anticâncer / Fator 2 de Elongação de Peptídeos / Fatores Imunológicos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fragmentos de Peptídeos / Linfócitos T Citotóxicos / Leucemia / Vacinas Anticâncer / Fator 2 de Elongação de Peptídeos / Fatores Imunológicos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2016 Tipo de documento: Article